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 Abstract 
 
MicroRNAs (miRNAs) are short, 20-22 nucleotide RNA molecules that function 
as negative regulators of gene expression in eukaryotic organisms. RNA mediated 
gene silencing pathways have essential roles in development, cell differentiation, 
proliferation, and cell death. It is becoming clear that microRNAs can play a very 
important role in regulation of gene expression. Understanding the basic mechanism 
of miRNA biogenesis is one of the central aims of molecular biologists in the future. 
MicroRNA molecules are produced from hairpin precursors formed from large 
transcripts. Two RNase III endonucleases, Drosha and Dicer, cleave both strands of 
the RNA and generate 20-22 nucleotide miRNA duplex. One arm of the duplex is 
selected and incorporated into RNA-induced silencing complex (RISC). RISC was 
identified earlier to repress the translation of mRNA in the presence of small 
interfering RNAs (siRNAs) by RNA interference (RNAi) mechanism. In animal cells, 
single-stranded miRNAs associated with RISC usually bind to target mRNAs through 
partial base-pairing, and result in translational repression. In plants, most miRNAs 
trigger mRNA cleavage through perfect base-pairing between miRNAs and target 
mRNAs. MiRNAs play important roles in development and diseases of plants and 
animals. There might be a possibility to use these microRNA signatures for a specific 
cancer classification with potential predictive and therapeutic value. MicroRNAs are 
aberrantly expressed in all studied cancer tissues. They are often located in 
cancer-associated genomic regions, act as tumor suppressors or oncogenes. For 
instance, miR-17–92, miR-155, miR-21, which are over expressed in tumors, might 
be considered as oncogenes. MiRNAs, such as let-7, which expression is reduced in 
cancer cells, can act as tumor-suppressor.  
 
The aim of this paper is to summarize the main findings from research on miRNA 
biogenesis, functionality and cancer relevance. A narrative literature review of 
relevant papers known to the authors was conducted.  
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Introduction 
 
MicroRNAs (miRNAs) comprise a new class of regulatory genes that function as 
20–25 nucleotide (nt) singlestranded RNAs to control the expression of 
protein-coding genes (Bartel, 2004). The first miRNA, lin-4, and its protein target, 
lin-14, were discovered in C. elegans in the Ambros and Ruvkun labs. It was found 
that lin-4 gene did not encode proteins, but encode a 21 nucleotide RNA that partially 
base-pairs with multiple sites in the 3’ UTR of lin-14, causing inhibition of lin-14 
protein expression (Lee et al, 1993; Wightman et al, 1993). Because the lin-14 mRNA 
level and polyribosome association appeared to be unchanged by lin-4, they suggested 
that miRNAs repress protein expression at the translational level (Olsen et al, 1999; 
Wightman et al, 1993). Further studies in C. elegans identified lin-28 as another target 
of lin-4, and lin-28 is regulated by lin-4 through translational inhibition as well (Moss 
et al, 1997; Seggerson et al, 2002). 
 
Almost all scientists did not pay any attention to the new class of small RNAs until 
let-7 was discovered in C. elegans sever years latter. Let-7 regulates late larval 
development by inhibiting lin-41 expression (Reinhart et al, 2000; Slack et al, 2000). 
The sequence and developmental expression pattern of let-7 were highly conserved in 
a wide range of animal species, including vertebrate, ascidian, hemichordate, mollusk, 
annelid, and arthropod (Pasquinelli et al, 2000), suggesting that let-7 plays important 
roles in biological processes in animals. This finding attracted lots of attention from 
scientists. MiRNA lin-4 and let-7 are recognized as the founding members of 
miRNAs.  
 
Each miRNA is thought to regulate multiple genes, hundreds of miRNA genes are 
predicted and several hundreds have been cloned and sequenced from C. elegans, 
Drosophila, Arabidopsis, mice and humans. The large number of miRNAs and 
homologous sequences of many miRNAs among organisms suggests that these RNAs 
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 might constitute an abundant component of the gene regulatory machinery with an 
ancient origin. In the past few years, a huge amount of papers related to miRNA have 
been published, and miRNA related research has become the hottest research fields in 
biology. In 2006, the Nobel Prize in Physiology or medicine was awarded to Andrew 
Z. Fire and Craig C. Mello for their discovery of RNA interference-gene silencing by 
double-stranded RNA.  
 
 
Biogenesis of miRNA 
 
Most miRNA genes are located far from protein coding genes. They might have their 
own promoters and are transcribed independently. However, some miRNA genes, 1/4 
of human miRNA genes are located in introns (Lee et al., 2003). They are transcribed 
along with the protein coding genes, and are spliced out during processing. Because 
miRNA genes and their host protein genes are co-transcribed, their relationship is 
often conserved in evolution. MiRNAs do not show a lot variety among different 
species. Some of miRNA genes are clustered on chromosomes. These are transcribed 
from a shared promoter. Although this kind of transcription is seldom in nematodes 
and human beings (Lim et al., 2003a, 2003b), half of the miRNA genes in Drosophila 
are found clustered (Aravin et al., 2003). Those miRNAs genes which are clustered 
usually have relationships with each other. For example, the human mir-15a-mir-16 
gene cluster is located in an anti-oncogene on chromosome 13, and down-regulation 
of these miRNAs caused leukemia (Calin et al, 2002). This indicates that both 
miR-15a and miR-16 are related to the cancer (Calin et al, 2002).  
 
Currently, we still know little about how the miRNA genes are transcribed to 
pri-miRNAs1. It is proposed that both the RNA polymerase II and III can participate 
in miRNA transcription. There is no doubt that the miRNA genes located in the 
protein gene introns are transcribed by the polymerase II. Although most of other 
                                                        
1 pri-miRNA: primary microRNA, several hundred nucleotides long miRNA precursor. 
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 miRNA genes lack the signal of poly adenylation (Ohler et al., 2004), we still have 
some indirect proofs which indicate that they may also be the transcription products 
of polymerase II (Bartel, 2004): 
A. Some pri-miRNAs are very long, sometimes longer than 1 kb. They are longer 
than the transcription products of polymerase III.  
B. The internal runs of uridine residue in some pri-miRNAs would be expected to 
prematurely terminate the polymerase III transcription. 
C. Many miRNA genes are expressed during the process of growth. This is more 
familiar in polymerase II than in polymerase III. 
D. Fusions were made by placing the open reading frame of the reporter gene 
downstream from the 5’ portion promotor of miRNA genes. Abundant reporter gene 
expression was observed. It is suggested that the pri-miRNA transcripts are 5’ capped 
which is the characteristic of polymerase II transcripts (Johnson et al., 2003).  
 
The first step of the pri-miRNA cleavage is completed by the RNase III Drosha which 
generates ~70 nucleotides pre-miRNA2 (figure 1). The pre-miRNA is formed as a 
stem loop structure and has 5’ phosphate and 3’ ~2 nucleotides overhang which is 
formed by the Drosha cleavage. Drosha contains 2 tandem RNase III domains: one 
dsRNA binding domain, another amino terminal segment of unknown function (Lee et 
al., 2003). The efficiency of Drosha processing is determined by its terminal loop size; 
stem structure, and flanking sequence of the Drosha cleavage site (Lee et al., 2003; 
Zeng, 2003). Drosha is an important component in the process of pri-miRNA cleavage, 
but there is also another protein Pasha. We still don’t clearly know the function of 
Pasha, but it may participate in identifying the transcripts of miRNA genes and 
incorporate them into the complex (Zamore et al, 2005). 
 
After pre-miRNAs are formed in the nucleus, they are transported into cytoplasm by 
Exportin 5 (Exp 5) which is a Ran-GTP dependent nucleo/cytoplasmic cargo 
                                                        
2 Pre-miRNA: precursor microRNA, an 70~nt intermediate with stem loop miRNA precursor. 
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 transporter (figure 1). As a result of the high concentration of Ran-GTP in nucleus, 
pre-miRNAs are released from Drosha and integrated into Exportin 5. When 
pre-miRNAs are transported into the cytoplasm where the Ran-GTP concentration is 
lower; then pre-miRNAs are released from Exportin 5 (Bohnsack et al, 2004). 
 
Figure 1: The biogenesis of miRNA (Adapted form 
Bartel 2004). 
1. Pri-miRNA is transcribed from miRNA genes. 
2. Pri-miRNA is cleaved by Drosha to pre-miRNA. 
3. Pre-miRNA is transported into cytoplasm. 
4. Pre-miRNA is cleaved by Dicer to miRNA: miRNA* 
duplex. 
5. MiRNA: miRNA* duplex is unwound by Helicase. 
6. MiRNA and miRNA* are selectively incorporated into 
the RISC. 
 
Once the pre-miRNAs are transported into cytoplasm, the maturation of miRNA is 
processed by another RNase III enzyme Dicer (Lee et al., 2003) (figure 1). Dicer was 
first discovered in generating siRNAs3 in RNAi (Bernstein et al., 2001). Later it is 
found that it is also the key enzyme in the maturation of miRNAs (Grishok et al., 
2001; Hutvagner et al., 2001; Ketting et al., 2001). The process Dicer performs in 
                                                        
3 siRNAs: short interfering RNAs,exogenous, 21-23 bp, dsRNA. 
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 miRNA maturation is similar to the formation of dsRNA in RNA interference. Dicer 
contains 2 tandem RNase Ⅲ domain, a putative helicase domain, a DUF283 domain, 
and a PAZ (Piwi-Argonaute-Zwille) domain (Bernstein et al, 2001). The PAZ domain 
recognizes the end of the Drosha cleavage, and therefore positions the site of the 
second RNase III cleavage on the stem structure of the miRNA precursors. In the 
process of cleavage, firstly, Dicer recognizes the double strand portion of 
pre-miRNAs, probably with special affinity to the 5’ phosphate and 3’ 2 nucleotides 
overhang generated by Drosha (Bartel 2004). Then it cuts both strands of the duplex, 
leaving 5’phosphate 3’ 2 nucleotides overhang, which is similar to siRNA but with 
imperfect complementarity. This new formed duplex is called miRNA:miRNA* 
duplex. 
 
RISC assembly 
 
MicroRNAs were first reported to reside in miRNP4 which is short for microRNA 
ribonucleoprotein complex. In human, miRNP consists of elF2C2, Gemin3, and 
Gemin4 (Mourelatos, et al, 2002). ElF2C2 was later found to be a constituent of the 
human siRNA- programmed RISC (Martinez, et al, 2002). Furthermore, the human 
let-7 miRNA is found to be associated with elF2C2, and is able to guide cleavage of 
an artificial target with perfect complementarity to the miRNA (Hutvagner, et al, 
2002). Thus, the miRNP is referred to as the RISC5. It is also supported by the 
evidence that plant miRNAs can direct cleavage of their targets (Llave, et al, 2002b; 
Tang, et al, 2003), and siRNA can also mediate translational repression (Doench, et al, 
2003; Zeng, et al, 2003). 
 
MiRNAs and siRNAs present in functional RISC have to be single stranded for 
pairing with the target RNA. There is a bias in the strand selection to incorporate into 
                                                        
4 miRNP: micro ribonucleoprotein complex. 
5 RISC: RNA induced silencing complex 
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 the RISC. The strand incorporated into the RISC or selected as a miRNA is generally 
the one whose 5’ terminus is thermodynamically less stable in the duplex. 
Comparative sequence analysis demonstrated that the 5’ end of mature guiding 
strands6 have significantly lower thermodynamic stability compared to the 5’ end of 
the passenger strands7 in the stem of the pre-miRNA (Hutvagner, 2005). Transfection 
experiments in human cells show that chemically synthesized siRNAs which are 
efficient in gene silencing have similar thermodynamic profiles. The 5’ end of the 
guiding strands of the competent siRNAs is less stable than the 5’ end of the 
passenger strands (Khvorova, et al, 2003). In vitro experiments with chemically 
synthesized siRNAs and radio labeled RNA targets in Drosophila cell-free embryo 
extracts came to the same conclusion and provide additional insight into the 
mechanism of RISC assembly (Schwarz, et al, 2003). The relative thermodynamic 
strength of the first four nucleotide pairs of the 5’ end can be calculated by the 
nearest-neighbor method which monitors the thermodynamic properties of the two 5’ 
ends of siRNA. If a G:C base pair is altered to an I:C base pair in a closely symmetric 
siRNA, the modified strands will be more preferable for RISC assembly (Schwarz, et 
al, 2003). 
 
Before the formation of the active regulatory complex, the RISC loading complex 
(RLC) places single stranded miRNA or siRNA into RISC (figure 2). In Drosophila, it 
is found that in RLC the Dcr-2-R2D2 heterodimer senses the differential free energy 
of the duplex ends, and determines which strand is selected to incorporate into the 
RISC (Tomari, et al, 2004). Dcr-2 is a member of the Dicer family. R2D2 (shown as 
DadR in figure 2) binds to the more thermodynamically stable strand (passenger 
strand), and its binding is facilitated by the characteristic 5’ phosphate. The cleavage 
of the passenger strand requires the Argonaute8 catalytic activity. Argonaute proteins 
                                                        
6 Guiding strand: also called anti-sense strand, the strand incorporated into the RISC, its 5’ end is less 
thermodynamically stable. 
7 Passenger strand: also called sense strand, the strand is eliminated after the guiding strand incorporated into the 
RISC, its 5’ end is more thermodynamically stable. 
8 Argonaute: members of a highly conserved family of proteins involved in RNAi and miRNA pathways. 
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 are the core proteins in every described RNAi9 complex. They are approximately 
100kDa proteins sometimes called PPD proteins. They have two conserved domains, 
the PAZ domain, which was proposed to bind single stranded RNA (Lingel, et al, 
2003; Song, et al, 2003; Yan, et al, 2003), and the PIWI motif, which shows structural 
homology to the active center of RNase H (Ma, et al, 2005; Parker, et al, 2004; Parker, 
et al, 2005; Song, et al, 2004). Evidence supports that Argonaute proteins physically 
cooperates with small RNA loading machinery. In humans, the dsRNA binding 
domain of Dicer directly interacts with the PIWI domain of Ago2 protein (Pillai, et al, 
2004). Some other RISC associated proteins including VIG, Fragile X-related protein, 
and the nuclease Tudor-SN do not have defined roles in the RISC (Caudy, et al, 2002, 
2003; Ishizuka, et al, 2002). They could be accessory factors that modify the 
specificity or function of the RISC (Bartel, 2004). The RISC endonuclease, known as 
Slicer, is recruited after the other proteins in RISC have interacted with small RNAs 
(Bartel, 2004). 
 
After the guiding strand is selected to incorporate into the RISC, the passenger strand 
with higher 5’ end free energy profile is eliminated (figure 2). It is showed that the 
passenger strand is eliminated after unwinding in an in vitro experiment in fly embryo 
extract (Schwarz, et al, 2003), and it is through the same activity that Ago protein 
cleave the cognate RNA target (Lau, et al, 2005). It was doubted if the passenger 
strand was too small for Ago protein to target the mRNA. However, evidence shows 
that the exogenously added passenger strand can be cleaved by affinity purified 
human Ago2 containing single stranded RNA (Martinez, et al, 2004). 
                                                        
9 RNAi: RNA interference, the phenomenon whereby a dsRNA trigger leads to a sequence homology-dependent 
gene silencing. 
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Figure 2: RISC activation (Hutvagner 2005). 
The thermodynamically favored siRNA (A) and miRNA (B) strand are loaded into RISC. RLC: 
RISC loading complex. H: putative helicase. P: 5’ phosphate. OH: 3’ hydroxyl. Scissor: Argonaute 
catalytic activity. Open circle shows the thermodynamically less stable end of the siRNA and 
miRNA. DadR: Dicer associated double stranded RNA binding protein. (R2D2 in Drosophila, 
RDE-4 in C. elegans, HYL1, DRB4 in plants) (Tabara, et al, 2002; Han, et al, 2004; Hiraguri, et al, 
2005). 
 
Post-transcriptional regulation by miRNA 
 
Both miRNAs and siRNAs are able to target mRNA degradation or translation 
silencing in mammalian cells and plants (Hutvagner, et al, 2002b; Llave et al, 2002; 
Doench, et al, 2003; Zeng, et al, 2003) (figure 3). The choice is determined by the 
identity to the mRNA target (Bartel, 2004). If the mRNA target has perfect or nearly 
perfect complementarity to the miRNA, the miRNA will specify mRNA cleavage. 
Otherwise, miRNA will repress translation when mRNA target does not have 
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 sufficient complementarity to miRNA (Hutvagner, et al, 2002; Zeng, et al, 2002, 2003; 
Doench, et al, 2003). Argonaute (Ago) proteins are the essential components of RISCs. 
Of the four mammalian Argonautes, Ago1 to Ago 4, only one, Ago2 (often referred to 
as a Slicer), functions in RNAi by endonucleolytically cleaving mRNA in the middle 
of the mRNA-siRNA duplex, whereas all four seem to participate in miRNA mediated 
repression (Meister, et al, 2004; Liu, et al, 2004; Pillai, et al, 2004). In Drosophila, 
Ago1 is dedicated to the miRNA pathway and Ago2 functions in RNAi (Okamura, et 
al, 2004; Miyoshi, et al, 2005). 
 
Figure 3: The Actions of small silencing RNAs 
Left: Messenger RNA cleavage specified by a miRNA or siRNA. Black arrowhead indicates the 
site of cleavage 
  Right: Translational repression specified by miRNAs or siRNAs. 
 
MiRNA-directed mRNA degradation 
 
MiRNAs and siRNAs can direct endonucleolytic cleavage of mRNAs. 
 
The way that miRNAs and siRNAs control post-transcriptional gene expression is by 
directing endonuclease cleavage of the target mRNA. Such endonuclease cleavage 
was first demonstrated in cell cultures with exogenously provided dsRNAs (Tuschl et 
al, 1999; Hammond et al, 2000). But now, it is appreciated that some endogenous 
miRNAs in both plants and metazoans direct endonucleolytic cleavage (Llave et al 
2002; Yekta et al, 2004). Although some mismatches can be tolerated and still allow 
cleavage to occur, endonucleolytic cleavage is generally favored by perfect 
base-pairing between the miRNA and the mRNA. What should be payed attention to 
is the fact that base-pairing between the miRNA and the mRNA is not always 
sufficient to induce cleavage. It suggests that there can be additional requirements for 
a RISC complex to catalyze endonucleolytic cleavage (Chen 2004). Additional for the 
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 RISC complex is that there exists a specific Argonaute protein present within the 
RISC. In mammalian cells, both miRNAs and siRNAs are thought to be loaded into 
the same RISC, where they guide mRNA degradation or translation silencing 
depending on the complementarity of the target. In Drosophila, Argonaute2 (AGO2), 
as part of the RISC complex, is essential for siRNA mediated RNAi in embryos 
(figure 4), and is required for the assembly of siRNA into RISC in embryos (Okamura 
et al. 2004). In contrast, Argonaute1 (AGO1), another Argonaute protein in fly, which 
is dispensable for siRNA-directed target RNA cleavage in RNAi (figure 4), is 
required for mature miRNA production that impacts on miRNA-directed RNA 
cleavage (Okamura et al. 2004) (figure 5). The association of AGO1 with Dicer-1 and 
pre-miRNA also suggests that AGO1 is involved in miRNA biogenesis (Okamura et 
al. 2004).  
  
Figure 4: AGO2 is necessary for siRNA mediated RNAi (Okamura et al. 2004).  
When AGO2 is suppressed by introducing specific dsRNA in S2 cells expressing EGFP, the ability 
of the cells to silence EGFP by RNAi is severely reduced. In contrast,  
When AGO1 is suppressed, the EGFP silencing effect is unaffected, indicating that AGO1 is not 
essential for the RNAi pathway in S2 cells. 
 
The general cellular mRNA degradation machinery 
 
The products of RNAi cleavage seems to be degraded by the same enzymes that 
degrade cellular mRNA. Eukaryotic cells contain two general and conserved 
pathways for the degradation of bulk mRNA, both of which require an initial removal 
of the 3’ poly (A) tail in a process referred to as deadenylation (Parker and Song 
2004). Deadenylation is followed by 3’ to 5’ exonucleolytic degradation by the  
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Figure 5: AGO1 is necessary for miRNA mediated RNAi (Okamura et al. 2004). 
In vitro RNAi assays with lysates prepared from 14- to 16-h yw, AGO2414, and AGO1k08121 
embryos. 
SiRNA directed its cleavage in AGO1k08121 embryo lysate as effectively as in wild type. 
However, cleavage of the target RNA directed by miR-2b was suppressed in AGO1k08121 
embryo lysate by a factor of five-fold copared with that in wild type, suggesting that AGO1 is 
necessary fro efficient target RNA cleavage mediated by miRNAs. 
exosome, a multimeric complex with 3’ to 5’ exonuclease activity. After 
deadenylation, mRNAs can be decapped by the Dcp1/Dcp2 decapping enzymes and 
degraded 5’ to 3’by the abundant 5’ to 3’ exoribonuclease. Following mRNA 
cleavage triggered by siRNAs or miRNAs, the 3’ fragment is degraded by major 
cellular 5’-to-3’ exonucleases.(Valencia-Sanchez et al. 2006). 
 
The degradation mode of the 5’ fragment from miRNA -induced cleavage is not so 
clear, and this fragment may be subject to two alternative fates. The first is that the 5’ 
fragment can be a substrate for the exosome; the second fate of the 5’product can be 
the addition of a 3’tail after the site of cleavage that includes predominantly Us, but 
can include As and Cs (Shen et al, 2004). This uridinylation occurs in both plants and 
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 animals and could be a mechanism to enhance degradation for poor substrates for the 
exosome, which might require a 3’ extension to activate the exosome 
(Valencia-Sanchez et al. 2006). Alternatively, uridinylation may compete with 3’ to 5’ 
degradation, and substrates where uridinylation occurs could end up being targeted for 
decapping and 5’ to 3’ degradation. 
 
MiRNAs can target mRNAs for slicer-independent decay 
 
MiRNAs can also target mRNAs for increased decay by a slicer-independent 
mechanism. An example in which miRNA can target mRNAs for decay is from the 
analysis of mRNA decay stimulated by an AU-rich 3’ UTR regulatory sequence 
(ARE). AREs are a class of sequences that control mRNA decay rates and translation 
in eukaryotic cells (Espel 2005). Recent studies suggested that the miR-16 functions 
with RISC and the sequence specific RNA binding protein to target an ARE 
containing mRNA for degradation (Jing et al, 2005). From the case of AU-rich 3’ 
UTR regulatory sequence (ARE)-mediated degradation, it suggests that the 
miRNA/RISC complex is not involved in exosome-mediated decay because RNAi 
inhibition of exosome function has no impact (Valencia-Sanchez et al. 2006). 
Evidencet that miRNAs might target mRNAs for decapping has come from 
comparing the subcellular distribution of Argonaute proteins with the decapping 
machinery. For eukaryotic cells, including yeast and mammals, the decapping 
enzymes are concentrated in specific cytoplasmic foci known as cytoplasmic 
processing bodies, also called P-bodies (Box 1), can be sites of mRNA decapping and 
degradation (Cougot et al, 2004). One of the Argonaute family members in C.elegans 
ALG-1(AGO-1) can accumulate in P-bodies (Ding et al, 2005). The mRNA targets of 
miRNAs also accumulate within P-bodies in a miRNA-dependent way (Liu et al. 
2005b). It was suggested that miRNAs target mRNAs into P-bodies, which increased 
their association with the decapping machinery and thereby potentially reduce their 
levels by decapping and 5’-to-3’ degradation (Valencia-Sanchez et al. 2006). 
 
In summary, miRNA combined with Argonaute proteins, either target mRNAs to 
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 promote mRNA decapping followed by 5’ to 3’ degradation, or to a clearly defined 
decay pathway.  
 
MiRNA-directed translational repression 
 
The mechanism of how miRNA induces the inhibition of translation is currently 
unknown. Efficient translation repression by miRNAs often requires multiple miRNA 
binding sites (Bartel, et al, 2004). The events during translation can be generally 
divided into three stages: initiation, elongation and termination. Several protein 
factors are involved at each stage. The available evidence indicates that miRNAs can 
repress translation at both initiation and post-initiation levels (figure 6). Some reports 
indicated that Argonaute proteins, miRNAs and mRNAs repressed by miRNAs all 
accumulate in discrete P-bodies (also known as GW bodies) (Sen, et al, 2005; Liu, et 
al, 2005; Meister, et al, 2005).  
 
Initiation is generally a rate-limiting step in translation and is frequently a subject of 
elaborate regulation, either affecting a specific mRNA or one with a global character 
(Pillai, et al, 2007). Evidence indicates that miRNAs can affect translation initiation 
which is supported by the fact that alterations in the translation initiation process can 
make an mRNA resistant to miRNA induced translation repression. Tethering of the 
translation factors elF-4E or eiF-4G to an mRNA makes it resistant to miRNA 
induced repression (Pillai, et al, 2005). Tethered translation initiation factors will still 
be repressed if miRNAs affect translation at a step after translation initiation. Some 
experimental results support that translation can be inhibited by miRNA at the 
initiation step (Pillai, et al, 2007). Polysome profile10 analysis of luciferase reporter 
mRNAs, expressed from transfected plasmid DNA and repressed by either 
endogenous let-7 miRNP or miRNA independent tethering of Ago proteins to a 
reporter mRNA, showed a marked shift of the repressed mRNAs towards the lighter 
fractions of a sucrose gradient, indicative of an effect at the initiation step of 
                                                        
10 Polysome profile: Density gradient cetrifugation of cytoplasmic extracts used to study the association of 
miRNAs with translational machinery. 
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 translation (Pillai, et al, 2005). Another experiment was taken with an endogenous 
miRNA target, cationic amino acid transporter 1 (CAT-1), which is regulated by 
miR-122 in liver and hepatoma cells. Under stress condition, when the miRNA 
mediated repression is relieved, a fraction of CAT-1 RMA shift from the lighter part of 
the gradient to the heavy region (Bhattacharyya, et al, 2006). Some other experiments 
suggest that miRNA can affect initiation by involving the m7G cap11 recognition 
(Pillai, et al, 2007). When the repression occurs at the initiation step of translation, 
run-off of ribosomes results in aggregation of the repressed ribosome-free mRNA into 
P-bodies for either degradation or storage. (Liu, et al, 2005) (figure 6a) 
 
Box 1: P-bodies 
P-bodies have been established as sites of translational repression and mRNA decay, and they are enriched in 
factors involved in these pathways (Anderson, et al, 2006; Coller et al, 2004). The decay factors include the 
deadenylase complex Ccr4:Not1, the decapping complex Dcp1:Dcp2, the 5’-3’ exonuclease Xrn1 (Parker, et 
al, 2004). The proteins in P-bodies with repressive activities on translation include Dhh1p, Rck/p54, elF4E-T 
and Part1p. Ribosomes and translation initiation factors do not exist in P-bodies, with the exception of elF4E. 
GW182, a protein with glycine-tryptophan repeats (GW repeats) is required for P-body integrity. Alternatively, 
GW182 could be involved in localizing miRNA targets to P-bodies or facilitating the RISC remodeling steps 
required for the silencing and/or decay of these targets (Jajymiw et al,2005; Liu et al, 2005b; Meister, et al, 
2005; Rehwinkel et al, 2005). There is an inverse correlation between polysome association and P-bodies 
accumulation of mRNAs (Bhattacharyya, et al, 2006; Pillai, et al, 2005; Coller, et al, 2005; Teixeiria, et al, 
2005; Brengues, et al, 2005). A block in the initiation step of translation leads to an increase in P-bodies size 
and number, due to the accumulation of inhibited miRNAs (Teixeiria, et al, 2005). On the other hand, drugs 
such as actinomycin D, which blocks mRNA synthesis, or cycloheximide, which retains mRNA on Polysomes, 
result in a loss of P-bodies (Andrei, et al, 2005; Cougot, et al, 2004). The fate of mRNAs accumulated in 
P-bodies depends on following general reactivation of cellular protein synthesis or in response to 
environmental stimuli. MRNAs can exit P-bodies and re-enter translation (Brengues, et al, 2005). As a result, 
P-bodies can function as temporary storage sites for inhibited mRNAs. 
 
 
 
 
 
 
                                                        
11 M7m7G cap: 7-methylguanylate cap of he 5’ end of nascent RNA transcripts. 
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 There could be two possible mechanisms of translational post-initiation repression by 
miRNAs. One is that ribosomes on the mRNA are slowed or stalled by miRNA 
(figure 6b), the other is that translation continues at the same rate but nascent 
polypeptide chains are specifically degraded by protease (figure 6c). The sucrose 
gradient and metrizamide-buoyant density gradients of the lin-4 target mRNAs 
remained largely unchanged under conditions of repression, suggesting that mRNAs 
are successfully loaded with ribosomes and that repression affects post-initiation steps 
of translation (Olsen, et al, 1999; Seggerson, et al, 2002). In this model, repressed 
mRNAs remain largely associated with ribosomes and thus might not relocate to 
P-bodies. Alternatively, association of repressed mRNAs with ribosomes could be 
caused by the ability of RISC to recruit proteolytic enzymes that would degrade 
nascent polypeptides from the actively translating ribosomes. However, the 
proteolysis might be fast, and occur early on short nascent peptides. Premature 
translation termination could yield incomplete, aberrant proteins undergoing rapid 
degradation. The inability to visualize nascent polypeptides might also indicate that 
they are simply not being synthesized, possibly owing to a block in translation 
initiation (Pillai, et al, 2007).  
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Figure 6:  Possible mechanisms of miRNA mediate repression of target mRNAs in metazoan 
cells. (Pillai, et al, 2007) 
(a). A two step mechanism commencing with a block in translation of the 7mG capped mRNA at the 
initiation step (Humphreys, et al, 2005; Pillai, et al, 2005). Run off of ribosomes results in 
aggregation of the repressed ribosome-free mRNA into P-bodies for either storage or degradation 
(Bhattacharyya, et al, 2006; Pillai, et al, 2005; Liu, et al, 2005).  
(b). Post-initiation mechanism representing repression of translation at the elongation or termination 
step, or promotion of ribosome drop off (Peterson et al, 2006). In this model, mRNAs remain largely 
associated with ribosomes and thus might not relocate to P-bodies. 
(c). Post-initiation mechanism involving rapid proteolysis of nascent polypeptide chains. There is no 
experimental support for this model. 
(d). miRNA mediated deadenylation and decay of target mRNAs (Behm-Ansmant, et al, 2006; Wu, 
et al, 2006; Giraldez, et al, 2006). The mRNA gets deadenylated by the Ccr4:Not1 deadenylase 
complex. The GW182 protein is important for P-body localization of Ago proteins and recruitment of 
the decay factors (Behm-Ansmant, et al, 2006; Jakymiw, et al, 2005; Ding, et al, 2005). 
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 MiRNA VS siRNA 
 
Fundamentally, miRNAs and siRNAs are similar in terms of their molecular 
characteristics, biogenesis and functions. They are generally 21-25 nucleotide small 
RNA molecules. Both of them are selectively incorporated into the silencing complex 
RISC, and bind to target mRNAs for post-transcriptional repression (figure 3). They 
share a common RNase-3 processing enzyme, Dicer, to form mature miRNAs or 
siRNAs. They can trigger a biological process, RNAi, which is sequence-specific 
gene silencing mechanism that is induced by dsRNA. They can also target mRNAs 
for translational repression. 
 
However, miRNAs and siRNAs are different in many facts, particularly in regard to 
their origin, evolutionary conservation, and the types of genes that they silence. First, 
miRNA derive from genomic loci distinct from other recognized genes, whereas 
siRNAs originate from mRNAs, transposons, viruses, or heterochromatic DNA 
(Bartel, 2004). Second, miRNAs are processed from pre-miRNAs by Dicer, and 
pre-miRNAs which have stem hairpin structure derive from pri-miRNA by Drosha 
(figure 1), whereas siRNAs in C. Elegans and D. Melanogaster are processed from 
long double stranded RNA duplex or extended hairpins (Bartel, 2004). Third, one 
single miRNA:miRNA* duplex is generated from one arm of each pre-miRNA 
molecule, whereas multiple siRNA duplexes are generated from each siRNA 
precursor molecules (in lower organisms). Fourth, miRNA sequences are conserved in 
related organisms, whereas endogenous siRNA sequences are rarely conserved 
(Ambros, et al, 2003a). Fifth, in many cases, miRNAs bind to the target mRNA 3’ 
UTRs through imperfect complementarity at multiple sites, and therefore negatively 
regulate target expression at the translational level. By contrast, siRNA often from a 
perfect duplex with their targets at only one site, and therefore direct the cleavage of 
the target RNAs at the site of complementarity. However, there are some exceptions: 
miR-172, all characterized plant miRNAs anneal to their targets with nearly perfect 
complementarity at a single site, either in the coding region or in the UTRs, therefore 
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 directing their target mRNAs to destruction by cleavage and degradation (Chen, 2004; 
Llave, et al, 2002; Rhoades, et al, 2002). A similar example is that miR-196, nearly 
perfect base pairing to its target Hoxb8, directs cleavage of Hoxb8 mRNA both in 
mouse embryos and in cell culture (Yekta, et al, 2004). Conversely, when siRNAs do 
not have sufficient complementarity to their targets, siRNAs can trigger translational 
repression rather than mRNA cleavage in mammalian tissue culture (Doench, et al, 
2003). Sixth, another distinction can be made between miRNAs and siRNAs: 
miRNAs specify the silencing genes which are very different or far from the genes 
that miRNAs are produced from. By contrast, endogenous siRNAs typically specify 
the silencing of the same or very similar loci from which they originate (Bartel, 2004). 
For example, viruses, transposons, and the heterochromatic outer repeats of 
centromeres are silenced by the siRNAs which are generated from them.  
 
Although the two classes of silencing RNAs are difficult to be distinguished by either 
chemical composition or mechanism of action, distinctions above can be made to 
classify the small RNAs. As the fifth point mentioned above, the mechanism of 
silencing is mainly determined by the degree of complementarity, not by the fact that 
the small silencing RNA molecules. We are left with the question of whether miRNAs 
are truly different from siRNAs or whether our current understanding fails to 
functionally distinguish these two classes of small silencing RNAs under 
physiological conditions. 
 
Roles of miRNAs in Plants 
 
In plants, miRNAs pair to mRNAs with near-perfect complementarity, and it can 
direct cleavage of targets mRNAs. Plant miRNAs play an important role in many 
aspects, including development, and plant diseases. 
 
DCL1 (Dicer-like enzyme 1) is an important enzyme that is involved in miRNA 
maturation (Park et al, 2002; Reinhart et al, 2002; Papp et al, 2003; Kurihara et al, 
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 2004; Liu et al, 2005). Loss-of-function of the DCL1 gene reduced the expression 
level of mature miRNAs and consequently caused many developmental abnormalities, 
including arrested embryos at early stages, altered leaf shape and morphology, 
delayed floral transition, and female sterility (Liu et al, 2005; Kurihara et al, 2006; 
Park et al, 2002; Reinhart et al, 2002;). HASTY is an ortholog of Exportin 5, which 
transports pre-miRNA from the nucleus to the cytoplasm. Loss-of-function of the 
HASTY gene also caused developmental abnormalities, such as disrupting leaf shape, 
flower morphology, accelerating phase change, and reducing fertility (Bollman et al, 
2003). These findings indicate that plant miRNAs play an important role in 
development process at different organ level, including roots, stems, shoots, and 
flowers. 
 
The plant miRNAs have a remarkable tendency for targeting transcription factor gene 
families, particularly those with known or suspected roles in plant development 
(Rhoades et al, 2002) (Table 1). MiRNAs control leaf development by regulating the 
expression of class-3 homeodomain leucine zipper (HD-ZIP) transcription factor 
genes, which control leaf asymmetry pattern (Juarez et al, 2004). Mutations in these 
genes results in morphogenesis of leaf and vascular bundles in the stem (McConnell 
et al, 2001; Emery et al, 2003). Experiments demonstrated that these transcription 
factor genes are the targets of and regulated by miR-165 and miR-166 (Emery et al, 
2003; Bao et al, 2004; Bowman, 2004; Juarez et al, 2004; Mallory et al, 2004b; Zhong 
et al, 2004; Kim et al, 2005; Williams et al, 2005b; Ko et al, 2006). Abnormal 
expression of miR-165 and miR-166 resulted in leaf developmental abnormalities in 
many plant species, including Arabidopsis and corn (Juarez et al, 2004). MiRNAs 
control apical meristem development by targeting several members of the NAC 
(NAM/ATAF/CUC)-domain transcription factors that are important for embryogenic, 
floral, shoot and root development (Aida et al, 1997; Takada et al, 2001; Hibara et al, 
2003). Abnormal expression of miR-164 resulted in abnormal expression of 
NAC-domain transcription factor genes, consequently caused developmental 
abnormalities, including shoot and root development (Laufs et al, 2004; Mallory et al, 
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 2004a; Guo et al, 2005). 
 
Many plant miRNAs function during cellular differentiation by mediating the 
degradation of key regulatory gene transcripts in specific daughter cell lineages 
(Rhoades et al, 2002). During differentiation, certain genes specifying a less 
differentiated state need to be turned off by repressing transcription. A gene is not 
fully turned off until its mRNA stops translating. To make it happen more quickly, 
miRNA in the differentiating cell can specify the cleavage of that mRNA. This could 
result in rapid cell differentiation without having to depend on regulatory genes 
having constitutively unstable messages (Bartel 2004).  
 
MiRNAs are also involved in plant diseases. Some of these miRNAs may get 
involved in virus-induced gene silencing. Helper component-proteinase (HC-pro), p19, 
p21, and p69, are unrelated viral suppressors of gene silencing and they play 
important roles in the virus response to plant antiviral silencing response (Plisson et al, 
2003; Chapman et al, 2004). Several lines of evidence indicate that miRNAs are 
related to the activity of these viral suppressors (Kasschau et al, 2003; Chapman et al, 
2004; Chen et al, 2004; Llave 2004). HC-pro inhibited the expression level and 
activity of mir-171, and caused miR-171 mediated developmental deficiency 
(Kasschau et al, 2003). P69 enhanced the expression and the activity of miRNAs, and 
caused rapid degradation of miRNA mediated mRNAs, and consequently enhanced 
plant resistance to pathogens (Chen et al, 2004). Bacterial flagellin-derived peptide 
induced an over expression of miR-933 in Arabidopsis (Navarro et al, 2006). 
MiR-933 negatively regulated F-box auxin receptors (TIR1, AFB1, AFB2, and AFB3), 
and resulted in inhibited bacteria Pseudomonas syringae growth and increased plant 
resistance to pathogens (Navarro et al, 2006). 
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 Roles of miRNAs in animals 
 
In animals, it is more difficult to identify miRNAs targets than in plants because in 
animals there are far fewer mRNAs with near-perfect complementarity to miRNAs. 
This makes the analysis much more prone to false positives. Evolutionary 
conservation was used as a criterion for target identification, but it could not be used 
as a tool to independently validate the targets (Bartel 2004). However, experimental 
evidence supports a majority of the predictions (Table 1). The function of animal 
miRNAs has been studied by several approaches. As we know, Dicer and Argonaute 
proteins are two important enzymes in biogenesis and functions of miRNAs 
(Hutvagner et al, 2001). Loss-of-function of these two enzymes decreases the 
expression of global miRNAs and can be used to study the global functions of 
miRNAs (Meister et al, 2004; Karube et al, 2005). Knockdown or knockdown or 
overexpression of specific miRNAs is a good approach to investigate the specific 
function of a unique miRNA (Hutvagner et al, 2004; Meister et al, 2004a; Lee et al, 
2005). Recently developed miRNA microarray technology and miRNA specific 
real-time PCR also provide useful information on miRNA functions (Miska et al, 
2004; Bartel et al, 2005; Liang et al, 2005).  
 
MiRNAs regulate differentiation 
 
Two founding member of the class of miRNAs, also the best-studied miRNAs, lin-4 
and let-7, regulate differentiation in C. elegans (Lee et al, 1993; Wightman et al, 1993; 
Reinhart et al, 2000). Loss-of-function of lin-4 and let-7 miRNAs results in abnormal 
differentiation. Lin-4 controls worm development at an early stage at the first larval 
stage (L1) and controls worm developmental transition from the L1 stage to the L2 
stage by negatively regulating the expression of two genes lin-14 and lin-28 (Lee et al, 
1993). Let-7 controls worm development at a late stage and controls worm 
developmental transition from the L2 stage to L3 stage by negatively regulating the 
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 expression of another two genes lin-41 and hbl-1 (Reinhart et al, 2000).  
 
MiRNAs regulate development 
 
MiRNAs regulate animal development in multiple tissues and at multiple 
developmental stages. Evidence indicates that miRNAs are important for the 
development of almost all animal tissues, including stem cells, embryo, brain, heart , 
limb, liver and other tissues (Lagos-Quintana et al, 2002; Houbaviy et al, 2003; Suh et 
al, 2004; Lee et al, 2005;Biemar et al, 2005; Schulman et al, 2005; Wienholds et al, 
2005; Yang et al, 2005; Krichevsky et al, 2003; Miska et al, 2004; Nelson et al, 
2005;Wu et al, 2005; Schubert, 2005; Hornstein et al, 2005; Murchison et al, 2005) 
(Table 2). For example, in zebrafish, maternal-zygotic dicer (MZdicer) mutant 
undergo axis formation and differentiate multiple cell type but display abnormal 
morphogenesis during gastrulation, brain formation, somatogenesis and heart 
development (Giraldez et al, 2005). HOX is an important group of genes in animal 
development, and it is negatively regulated by miR-196 and miR-181 (Yekta et al, 
2004, Naguibneva et al, 2006). Abnormal expression of these miRNAs causes 
abnormal expression of HOX, and results in animal developmental abnormality 
(Mansfield et al, 2004; Yekta et al, 2004; Guenther et al, 2005; Naguibneva et al, 
2006). Recent research found that a cardiac-specific miRNA (miR-208) is required for 
cardiomyocyte hypertrophy, fibrosis, and expression of bMHC (β-myosin heavy 
chain, the primary contractile protein of the heart) in response to stress and 
hypothyroidism, which results from down-regulated αMHC and up-regulated β
MHC by miR-208 (Rooij et al, 2007). 
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miRNA Target genes Biological role of miRNA/target gene 
Nematodes 
lin-4 
 
let-7 
 
isy-6 
Insects 
bantam miRNA 
miR-14 
 
  
miR-7 
 
 
Mammals 
miR-181 
miR-1 
 
miR-19a 
miR-23a 
 
miR-26a 
miR-34 
 
miR-101 
 
miR-130 
Plants 
miR-165/166 
miR-172 
miR-JAW 
miR-159 
miR-170/171 
miR-156/157 
miR-160 
miR-167 
miR-164 
miR-169 
miR-162 
 
Ce lin-14 probable transcription factor 
Ce lin-28 cold shock domain protein 
Ce lin-41 probable RNA-binding protein 
Ce hbl-1 transcription factor 
Ce cog-1 transcription factor 
 
Dm hid pro-apoptotic protein 
Dm grim antagonist of caspase inhibitor 
Dm reaper antagonist of caspase inhibitor 
Dm sickle antagonist of caspase inhibitor 
Dm HLHm3 basic HLH transcriptional repressor 
Dm hairy basic HLH transcriptional repressor 
Dm m4 Brd family protein 
 
unknown 
Hs Brain-derived neurotropic factor (BDNF) 
Hs Glucose-6-phosphate dehydrogenase (G6PD) 
Hs Ptdina (3,4,5) P3 phosphatase (PTEN) 
Hs Stromal cell-derived factor 1 (SDF-1) 
Hs BRN-3b POU-domain transcription factor 
Hs SMAD-1 transcriptional co-modulator 
Hs Delta 1 transmembrane protein 
Hs Notch 1 transmembrane receptor for Delta 
Hs ENX-1 polycomb gene 
Hs N-MYC basic HLH transcription factor 
Hs Macrophage colony stimulating factor-1 
 
At REV and related transcription factors 
At AP2 and related transcription factors 
At TCP4 and related transcription factors 
At MYB33 and related transcription factors 
At SCL6-3,4 & related transcription factors 
At SPL2 & related transcription factors 
At ARF10, ARF17 & related transcription factors 
At ARF8 & ARF6 transcription factors 
At CUC1, CUC2 & related transcription factors 
At CBF-HAP2 DNA-binding proteins 
At DCL1 Dicer-like RNase 3 
 
Timing of early larval developmental transitions 
Timing of early larval developmental transitions 
Timing of late larval developmental transitions 
Timing of late larval developmental transitions 
Left/right asymmetry of chemoreceptor expression 
 
Apoptosis and growth control during development 
Promotes apoptosis 
Promotes apoptosis 
Promotes apoptosis 
Interprets Notch-mediated decisions in neuronal development 
Interprets Notch-mediated decisions in neuronal development 
Interprets Notch-mediated decisions in neuronal development 
 
Hematopoietic differentiation 
Growth factor, neuronal development 
Oxidative stress resistance 
Tumor suppressor gene 
Growth and localization of hematopoletic progenitor cells 
Neuronal development 
Regulates TGF-dependent gene expressioni 
Activates Notch during cell-fate decisions 
Cell-fate decisions during development 
Proliferation of hemotpoeitic cells and other gene regulation 
Proto-oncogene; cell differentiation and proliferation 
Mononuclear phagocytic lineage regulation  
 
Axial meristem initiation and leaf development 
Flower development; timing transition to flowring 
Leaf development, embryonic patterning 
Leaf development 
Related to genes for root radical patterning 
Related to genes for floral meristem identity 
Related to genes for auxin response & development 
Related to genes for auxin response & development 
Shoot apical meristem formation & organ separation 
unkown 
miRNA biogenesis 
 
Table 1: MiRNAs and their functions (modified from Bartel 2004) 
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 Species abbreviation: Ce: Caenorhabditis elegans; Dm: Drosophila melanogaster; Hs: human; At: Arabidopsis 
thaliana 
(Lee et al, 1993; Wightman et al, 1993; Moss et al, 1997; Reihart et al, 2000; Slack et al, 2000; Abrahante et al, 
2003; Lin et al, 2003; Johnston et al, 2003; Brennecke et al, 2003; Chen et al, 2004; Rhoades et al, 2002; Tang et al, 
2003; Emery et al, 2003; Park et al, 2002; Kasschau et al, 2003; Chen 2003; Aukeman et al 2003; Palatnik et al, 
2003; Lai 2002; Stark et al, 2003; Lewis et al, 2003; Llave et al, 2002a, 2002b; Xie et al, 2003; Bartel et al, 2003) 
 
MiRNAs regulate cell death and fat metabolism 
 
The Drosophila miRNA miR-14 suppresses cell death and is required for normal fat 
metabolism. Loss-of-function of miR-14 enhances Reaper-dependent cell death, 
where as ectopic expression suppresses cell death induced by multiple stimuli. 
MiR-14 also regulates fat metabolism. Deletion of miR-14 results in animals with 
increased levels of triacylglycerol and diacylglycerol, whereas increases in miR-14 
copy number have the opposite effect (Xu et al, 2003). 
 
Expression pattern MiRNAs 
Enriched in brain 
miR-12a, miR-125b, miR-128, miR-132, miR-139, miR-7, miR-9, miR-124a, miR-124b, 
miR-135, miR-153, miR-149, miR-183, miR-190, miR-219 
Enriched in lung 
miR-18, miR-19a, miR-24, miR-32, miR-130, miR-213, miR-20, miR-141, miR-193, 
miR-200b 
Enriched in spleen miR-99a, miR-127, miR-142a, miR-142s, miR-151, miR-189, miR-212 
Enriched in liver miR-122a, miR-152, miR-194, miR-199, miR-215 
Enriched in heart miR-1b, miR-1d, miR-133, miR-206, miR-208, miR-143 
Enriched in kidney miR-30b, miR-30c, miR-18, miR-20, miR-24, miR-32, miR-141, miR-193, miR-200b 
Enriched in haematopoetic tissues miR-181, miR-223, miR-142 
Enriched in β-cells of the pancreas miR-375, miR-125b 
Ubiquitously expressed miR-16, miR-26a, miR-27a, miR-143a, miR-21, let-7a, miR-7b, miR-30b, miR-30c 
 
Table 2: Tissue-specific miRNA expression signature (Houbaviy et al, 2003; krichevsky et al, 
2003; Liu et al, 2004; Sempere et al, 2004; Poy et al, 2005) 
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 MiRNAs and human disease 
 
MiRNAs are involved in a broad spectrum of human disease. Fragile X mental 
retardation (FXMR), a neurological disease in which miRNAs or their processing 
machinery have been induced, is caused by absence or mutation of the fragile X 
mental retardation protein. Experimental results from Drosophila melanogaster 
indicate that FXMR may be a part of RISC (Ishizuka et al, 2002).  
 
Mir-224 gene locus lies within the minimal candidate region of two different diseases: 
X-linked mental retardation and early onset Parkinson’s disease (Dostie et al, 2003). 
Over-expression of miR-375 suppresses glucose-induced insulin secretion and could 
represent a novel pharmacological target (Poy et al, 2004). 
 
MiRNAs maybe also involved in virus-related or induced disease and immune 
defense (Lecellier et al, 2005). MiR-32 mediates antiviral defense in human cells, and 
regulate primate foamy virus type I (PFV-1) proliferation (Lecellier et al, 2005).  
MiR-155 plays a key role in the homeostasis and function of the immune system, and 
it is required for the function of B and T lymphocytes and dendritic cells (Rodriguez 
et al, 2007).  
 
One of the biggest progresses on miRNAs was the finding that miRNAs play an 
important role in cancer pathogenesis. About 50% of miRNA genes are localized in 
cancer-associated genomic regions or in fragile sites (Calin et al, 2004). The 
prediction number of miRNAs in the human genome is as many as 1000 (1-5% of the 
predicted genes in the genome). MiRNAs may act as a novel class of oncogenes or 
tumor suppressor genes (figure 7) (Box 2). They relate to many common and 
important cancers, including cancers in lung, brain, breast, blood, liver, colon, 
lymphomas, thyroid, and testicular germ cell (Zhang et al, 2006f) (Table 3).  
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 Box 2: Ooncogenes and tumor suppressor genes 
 
Cancer-critical genes are grouped into two broad classes, according to whether the cancer risk arises from too 
much avtivity of the gene product, or too little. Genes of the first class, for which a gain-of-function mutation 
drives a cell toward cancer, are called proto-oncogenes; their mutant, overactive forms are called oncogenes. 
Genes of the second class, for which a loss-of-function mutation creates the danger, are called tumor 
suppressor genes. 
Cancer type Aberrantly regulated miRNAs 
CLL-chronic lymphocytic leukemia  
miR-15a and miR-16-1, down regulated in more than 60\% of CLL cases 
miR-155/BIC RNA, increased levels 
miR-17-92 cluster, only some members are abnormally expressed 
miR213, miR-183,miR-190, miR-21-1, miRNAs located exactly inside fragile 
sites 
miR-96, miR-182, miR-183=7q32 group, all members are aberrantly regulated 
CLL-distinguish CLL samples that express unmutated IgVh gene from 
those that express mutated IgVh gene 
miR-186, miR-132, miR-16-4, miR-102, miR-29c 
CLL-13 miRNAs prognostic group, could discriminate between CLL 
samples that express ZAP-70 and unmutated IgVh and CLL samples that 
have no expression of ZAP and have amutated IgVh 
miR-15a, miR-195, miR-233 miR-24-1, miR-29b-2, miR-29a-2, miR-16-1, 
miR-16-2, miR-155, miR-146, miR-221, miR-23b, miR-29c 
CLL-9 miRNAs predicting interval fromdiagnosis to therapy, 
differentiate patients with a short interval from diagnosis from patients 
with a longer intervals  
miR-155, miR-146, miR-221, miR-23b, miR-29c, miR-222, miR-24-2, miR-23a, 
miR-181a 
Diffuse large B cell lymphoma, marginal zone lymphomas, other 
non-Hodgkin lymphomas and Hodgkin lymphomas 
miR-155/BIC RNA, increased levels 
Aggressive B cell leukemia 
miR-152 translocation t(8,17) causes up-regulation of a translocated c-MYC 
gene 
Breast cancer 
miR-10b, miR-125b, miR-145 down-regulated 
miR-21, miR-155, up-regulated 
Lung cancer 
Let-7, reduced expression 
miR-155, over-expression 
miR17-92 cluster, over-expression 
glioblastoma 
miR-221, miR-21, strongly over-expressed 
miR-128, miR-181a, miR-181b, miR-181c, down -regulated 
Colorectal tumors  miR-143, miR145, down-regulated 
Table 3: MiRNAs associated with cancer diseases (Kusenda et al, 2006) 
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Figure 7: Possible “oncogenic” and “tumor suppressing” miRNAs (Kusenda et al, 2006) 
 
Let-7 regulates lung cancer pathogenesis by negatively regulating the expression of 
the oncogene RAS (Johnson et al, 2005). RAS is a well-studied oncogene which 
interferes with p53 pathway in lung cancer, leading to apoptosis, and it has multiple 
complementarity sites to let-7 in its 3’UTR (Johnson et al, 2005). Thus let-7 inhibited 
RAS mRNA translation, and inhibited lung tumor cell differentiation and growth 
(Johnson et al, 2005). A recent study demonstrated that the expression of let-7 was 
significantly reduced while the expression of RAS was dramatically increased in lung 
tumor tissues (Johnson et al, 2005). This suggests that miRNA let-7 may function as a 
tumor suppressor gene in human and other mammalians (figure 7).  
 
Evidence indicates that in leukemic cells with a deletion of the locus on chromosome 
13 that contains miR-15a and miR-16-1 miRNA genes (Calin et al, 2002), cancer is 
induced as a result of the down-expression of these miRNAs, in more than 60% of 
CLL cases (Calin et al, 2002). It was demonstrated that a possible target for miR-15a 
and miR-16-1, BCL2, is negatively regulated by both miRNAs at a 
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 post-transcriptional level. The expression of both miRNAs is inversely correlated to 
BCL2 expression in CLL (Cimmino et al, 2005). Moreover, in a leukemic cell line 
model, BCL2 repression by these miRNAs induces apoptosis (Cimmino et al, 2005) 
(figure 7). This suggests that deregulation of anti-apoptotic BCL2 in CLL cells could 
be a key event in cancerogenesis. 
 
MiR-21, the only miRNA overexpressed in all types of cancer analysed, is also 
overexpressed in glioblastomas and cholangiocarcinomas (Clafre et al, 2005; Chan et 
al, 2005; Meng et al, 2006). It directly targets the tumor suppressor PTEN in 
cholangiocarcinoma cells. PTEN encodes a phosphatase that can inhibit growth and 
survival pathways (Ali et al, 1999). Furthermore, knockdown of miR-21 in 
glioblastoma cells triggers apoptosis by a caspase-dependent mechanism (Chan et al, 
2005). It is suggested that miR-21is an anti-apoptotic factor and can act as an 
oncogene. 
 
MiR-155 is a gene overexpressed in various types of B-cell malignancy (Metzler et al, 
2004; Eis e al, 2005; Kluiver et al, 2005). Its regulation could be an early event in 
oncogenesis that needs additional genetic alterations for the development of the fully 
malignant phenotype (Costinean et al, 2006). There are complex relationships exist 
between protein-coding genes and miRNAs that affect specific signaling pathways 
and, probably, direct or indirect interactions exist between miR-155 and some of the 
other deregulated miRNAs (George et al, 2006). 
 
The miR17-92 cluster is located at 13q31.3, a genomic locus that is amplified in cases 
of diffuse large B-cell lymphoma, follicular lymphoma, mantel cell lymphoma, 
primary cutaneous B-cell lymphoma and other tumor types (Knuutila et al, 1998; Ota 
et al, 2004). O’Donnel et al, 2005 showed that in the human B-cell line P493-6, which 
overexpress MYC, miRNA members of the miR-17-92 cluster have tumor suppressor 
activity because their expression decreases the expression of E2F1, and so inhibits 
MYC-mediated cellular proliferation (O’Donnel et al, 2005). However, a different 
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 perspective is offered by the results from B-cell lymphomas. The same cluster of 
miRNAs function as a potential oncogene by cooperating with MYC and blocking 
apoptosis (He et al, 2005). George et al, 2006 suggest that the same miRNA can 
participate in distinct pathways, having different effects on cell survival, growth and 
proliferation that are dependent on the cell type and the pattern of gene expression. 
The combinatorial nature of miRNA-miRNA interaction means that the same miRNA 
could have different targets and the same mRNA could be targeted by different 
miRNA in different cell types. 
 
Discussion 
 
A general model for gene post-transcriptional regulation by miRNA holds that perfect 
complementarity between a miRNA and its target mRNA results in cleavage of the 
mRNA, partial pairing of a miRNA and its target mRNA leads to translational 
repression without destabilization of the mRNA. However, evidence showed that 
regulation by lin-4 and let-7 miRNAs results in target mRNA degradation (Bagga et al, 
2005). It was originally reported that the association of lin-14 mRNA with 
polyribosomes appeared unchanged upon lin-4 mediated repression of protein 
expression (Olsen et al, 1999), and the lin-28 mRNA levels and polyribosome profile 
were also not altered when lin-4 blocked lin-28 protein accumulation (Moss et al, 
1997; Seggerson et al, 2002). Bagga et al used Northern analyses to compare the 
expression of full length intact endogenous mRNA targets of miRNA regulation, 
which leads to the different results. 
 
We think that the mechanism directed by a given miRNA could be dependent on 
multiple factors, including the composition of mRNA, the expression level of mRNA, 
and the miRNA cofactors. If the mRNA includes target sites which perfectly base pair 
to a miRNA, then RNAi is triggered and the mRNA is cleaved by Ago family. If the 
base pairing is insufficient, we propose that the mechanism may dependent on the 
 30
 mRNA level which is regulated by other mechanisms. When mRNA level is high, 
there could be two possibilities. First, the initiation of the translation is inhibited by 
miRNP interfering initiation factors (figure 6a). Run off of ribosomes results in 
accumulation of repressed ribosome-free mRNAs in to P-bodies for either storage or 
decay (Pillai, et al, 2005), which may cause the observation of mRNA level decrease. 
Second, miRNP recruits the deadenylase complex Ccr4:Not1 and the GW182 protein 
for mRNA decay (figure 6d). When the situation leads to a low level of mRNA, the 
mRNA will not destabilized by miRNAs. The translation may be repressed at 
post-initiation steps, at the elongation, or termination. In this model, mRNAs remain 
largely associated with ribosomes and thus may not relocate to P-bodies (figure 6b). 
Alternatively, rapid proteolysis of nascent polypeptide chains results in the decrease 
of the protein level (figure 6c), while the mRNA level remains unchanged. In 
summary, miRNA regulates its target mRNA dynamically either by directs mRNA 
cleavage, or leads to mRNA decay if necessary, consequently decreases the protein 
level. MiRNAs can down-regulate target mRNA and protein in different manner in 
multiple situations. Scientists used different experiment techniques could lead to the 
discrepant results. 
 
Abnormal expression of miRNA usually results in cancer. It was shown that more 
than half of the known human miRNAs reside in cancer-associated genomic regions 
that are prone to alteration in cancer cells (Calin et al, 2004). Additionally, alteration 
of the proteins involved in the biogenesis of miRNA should have dramatic effects on 
miRNA expression. As affecting important human oncogenic signaling pathway, 
miRNA can be a new clinical tool in cancer diagnosis and prognosis. Evidence 
indicates that the miRNA based cancer classifier is much better at establishing the 
correct diagnosis of the samples than the mRNA classifier (Lu et al, 2005). Profiling a 
few hundred miRNAs has a much better predictive power for diagnosis than profiling 
several tens of thousands of mRNA. MicroRNA profiling can also act as a prognostic 
tool. The identification of new prognostic markers, which correlate with disease 
evolution, could be a significant advance for the identification of patients that would 
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 benefit from more aggressive therapy. For example, in lung cancer, as illustrated 
above (table 3, figure 7), the existence of the link between let-7 and Ras expression 
could have impact on the life expectancy of patient with lung cancer. 
 
Conclusion 
 
Since the discovery of miRNAs in C. elegans, remarkable progress has been made in 
exploring the characterization of this gene family. It has been demonstrated that these 
small, no-coding RNAs are not only a new class of gene expression regulatory RNAs, 
but the outlines of the mechanism for their functions in gene regulation have emerged. 
However, with some exceptions, we know little about the precise mechanisms of the 
vast majority of miRNAs in regulating gene expression. Furthermore, the 
relationships between miRNAs, siRNAs and the proteins of the gene regulatory 
machinery remain to be explained. 
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